KRYS Krystal Biotech PE ratio, current and historical analysis
As of Oct 24, 2024, the KRYS stock has a PE ratio of 46.41. The calculation is based on the latest EPS of $3.77 and the stock price of $174.98 per share.
KRYS PE ratio history
Krystal Biotech PE ratio by year
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 310.15 | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | N/A | N/A |
| 2019 | N/A | N/A |
| 2018 | N/A | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
KRYS average PE ratio chart
KRYS PE vs peers
In comparison to its peer stock ORMP, KRYS's PE ratio is higher.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ORMP Oramed Pharmaceuticals Inc | 4.63 | $96.21M |
| KRYS Krystal Biotech Inc | 47.06 | $5.1B |
| OLMA Olema Pharmaceuticals Inc | N/A | $685.48M |
| OMER Omeros Corp | N/A | $246.27M |
| OMGA Omega Therapeutics Inc | N/A | $79.97M |
| ONCT Oncternal Therapeutics Inc | N/A | $4.41M |
| ONVO Organovo Holdings Inc | N/A | $7.24M |
| ORIC Oric Pharmaceuticals Inc | N/A | $594.67M |
Frequently asked questions
What is Krystal Biotech's PE ratio?
KRYS stock has a price to earnings ratio of 46.41 as of Oct 24, 2024.
How is KRYS's PE ratio calculated (Krystal Biotech PE ratio formula)?
The P/E ratio is obtained by dividing the latest price of a stock by its trailing twelve months EPS. As of today (Oct 24, 2024), Krystal Biotech's share price is $174.98. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2024 is $3.77. Therefore, Krystal Biotech's PE ratio for today is 46.41. PE RATIO(46.41) = STOCK PRICE($174.98) / TTM EPS($3.77)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.